These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8764352)

  • 1. Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
    Katsoulis S; Schmidt WE; Schwarzhoff R; Folsch UR; Jin JG; Grider JR; Makhlouf GM
    J Pharmacol Exp Ther; 1996 Jul; 278(1):199-204. PubMed ID: 8764352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory transmission in tenia coli mediated by distinct vasoactive intestinal peptide and apamin-sensitive pituitary adenylate cyclase activating peptide receptors.
    Jin JG; Katsoulis S; Schmidt WE; Grider JR
    J Pharmacol Exp Ther; 1994 Aug; 270(2):433-9. PubMed ID: 8071835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
    Ekblad E; Sundler F
    Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells.
    Murthy KS; Jin JG; Grider JR; Makhlouf GM
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1391-9. PubMed ID: 9227474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIP- and PACAP-mediated nonadrenergic, noncholinergic inhibition in longitudinal muscle of rat distal colon: involvement of activation of charybdotoxin- and apamin-sensitive K+ channels.
    Kishi M; Takeuchi T; Suthamnatpong N; Ishii T; Nishio H; Hata F; Takewaki T
    Br J Pharmacol; 1996 Oct; 119(4):623-30. PubMed ID: 8904634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the descending relaxation phase of intestinal peristalsis by PACAP.
    Grider JR; Katsoulis S; Schmidt WE; Jin JG
    J Auton Nerv Syst; 1994 Dec; 50(2):151-9. PubMed ID: 7884155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of PACAP(6-38) on relaxations induced by PACAP, VIP and non-adrenergic, non-cholinergic nerve stimulation in the guinea-pig taenia caeci.
    Lénárd L; Lázár Z; Benkó R; Szigeti R; Báthori Z; Tóth GK; Penke B; Barthó L
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):492-7. PubMed ID: 10832602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive mechanisms among pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide, and parathyroid hormone receptors in guinea pig cecal circular smooth muscle cells.
    Motomura Y; Chijiiwa Y; Iwakiri Y; Ochiai T; Nawata H
    Endocrinology; 1998 Jun; 139(6):2869-78. PubMed ID: 9607796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the NANC relaxation of the guinea-pig proximal colon longitudinal muscle by the purinoceptor antagonist PPADS, inhibition of nitric oxide synthase, but not by a PACAP/VIP antagonist.
    Rózsai B; Lázár Z; Benkó R; Barthó L
    Pharmacol Res; 2001 Jan; 43(1):83-7. PubMed ID: 11207070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of PACAP on guinea pig gallbladder muscle via PACAP-preferring and VIP/PACAP-preferring receptors.
    Parkman HP; Pagano AP; Ryan JP
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1433-8. PubMed ID: 9227479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon.
    Ekblad E
    Regul Pept; 1999 Dec; 85(2-3):87-92. PubMed ID: 10651061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
    Montpetit CJ; Perry SF
    J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.
    Hernández M; Barahona MV; Recio P; Rivera L; Benedito S; Martínez AC; García-Sacristán A; Orensanz LM; Prieto D
    Br J Pharmacol; 2004 Jan; 141(1):123-31. PubMed ID: 14662737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxant effects of pituitary adenylate cyclase activating polypeptide (PACAP) on epithelium-intact and -denuded guinea-pig trachea: a comparison with vasoactive intestinal peptide (VIP).
    Conroy DM; St-Pierre S; Sirois P
    Neuropeptides; 1995 Sep; 29(3):121-7. PubMed ID: 8538872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of nitrergic relaxant responses by peptides in the mouse gastric fundus.
    Baccari MC; Calamai F
    Regul Pept; 2001 Apr; 98(1-2):27-32. PubMed ID: 11179775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase activating peptide, a novel VIP-like gut-brain peptide, relaxes the guinea-pig taenia caeci via apamin-sensitive potassium channels.
    Schwörer H; Katsoulis S; Creutzfeldt W; Schmidt WE
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):511-4. PubMed ID: 1470223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PACAP and VIP inhibit pyloric muscle through VIP/PACAP-preferring receptors.
    Parkman HP; Pagano AP; Ryan JP
    Regul Pept; 1997 Aug; 71(3):185-90. PubMed ID: 9350977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.